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ABSTRACT: Ergothioneine (ERG) is a histidine-derived thiol compound suggested to function as an antioxidant and
cytoprotectant in humans. Therefore, experimental trials have been conducted applying ERG from mushrooms in dietary
supplements and as a cosmetic additive. However, this method of producing ERG is expensive; therefore, alternative methods for
ERG supply are required. Five Mycobacterium smegmatis genes, egtABCDE, have been conﬁrmed to be responsible for ERG
biosynthesis. This enabled us to develop practical fermentative ERG production by microorganisms. In this study, we carried out
heterologous and high-level production of ERG in Escherichia coli using the egt genes from M. smegmatis. By high production of
each of the Egt enzymes and elimination of bottlenecks in the substrate supply, we succeeded in constructing a production
system that yielded 24 mg/L (104 μM) secreted ERG.
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■ INTRODUCTION
Ergothioneine (ERG), a histidine-derived thiol compound, was
isolated from an ergot fungus, Claviceps purpurea, more than a
century ago. ERG is also known to be synthesized in
actinobacteria, cyanobacteria, and a ﬁssion yeast.1−3 Recent
studies show that ERG functions as an antioxidant, such as
glutathione, mycothiol, and bacillithiol. There is no direct
evidence for biosynthesis of ERG in humans. However, ERG
has been reported to be accumulated in various cells and tissues
at high concentrations, probably by intake from diets, such as
mushrooms and red beans, that contain relatively large amounts
of ERG through an ERG-speciﬁc organic cation transporter,
OCTN1.4,5
The presence of the ERG-speciﬁc transporter and the
extensive accumulation of ERG in tissues suggest that ERG
should have signiﬁcant biological functions in humans.
Although the true physiological role of ERG in humans has
yet to be fully understood, ERG has been shown by in vitro
experiments to function as an antioxidant and a cytoprotectant.
Therefore, applications of ERG in dietary supplements and as a
cosmetic additive have been explored, and there is an increasing
demand for ERG.6 Mushrooms have traditionally been the
source of ERG.7 However, slow growth, low content, and time-
consuming puriﬁcation procedures lead to a high manufactur-
ing cost. Therefore, alternative and sustainable sources of ERG
are necessary.
One such reliable and practical method is a fermentative
process using microorganisms, such as actinobacteria and
cyanobacteria, that are known to produce ERG. However, their
ERG productivities are very low (1.18 mg/g of dry weight after
4 weeks of cultivation of Mycobacterium avium and 0.8 mg/g of
dry weight of Oscillatoria sp.),2,8 and thus, genetic and
metabolic engineering are indispensable for industrial produc-
tion. Until recently, however, there were no reports on ERG
biosynthesis genes and enzymes. In 2010, ﬁve genes in
Mycobacterium smegmatis, egtABCDE, were conﬁrmed to be
responsible for ERG biosynthesis (Figure 1).9 In the
biosynthetic pathway, EgtD catalyzes the formation of
hercynine (HER) by transfer of three methyl groups derived
from S-adenosylmethionine (SAM) to L-histidine (L-His).
Then, EgtB catalyzes O2-dependent C−S bond formation
between γ-glutamylcysteine (γGC) supplied by EgtA and HER
to form hercynyl-γ-glutamylcysteine sulfoxide (γGC-HER).
This is followed by removal of the L-glutamate (L-Glu) moiety
by EgtC, an amidohydrolase, to produce hercynylcysteine
sulfoxide (Cys-HER). Then, EgtE, a PLP-dependent C−S lyase,
catalyzes the formation of ERG with concomitant formation of
pyruvate and ammonia as side products.
In this study, we developed heterologous and high-level
production of ERG in Escherichia coli using the egt genes from
M. smegmatis. By high production of each of the Egt enzymes
and elimination of bottlenecks in substrate supply, the
production system yielded 24 mg/L (104 μM) secreted ERG.
■ MATERIALS AND METHODS
General Procedures. Lysogeny broth (LB, Lennox) medium was
purchased from Sigma-Aldrich Japan K.K. (Tokyo, Japan); L-
methionine (L-Met) and L-His were obtained from Wako Pure
Chemical Industry (Osaka, Japan); and HER was purchased from
Shinsei Chemical Company, Ltd. (Osaka, Japan). Other chemicals
Received: October 24, 2017
Revised: December 22, 2017
Accepted: December 25, 2017
Published: December 25, 2017
Article
pubs.acs.org/JAFCCite This: J. Agric. Food Chem. 2018, 66, 1191−1196
© 2017 American Chemical Society 1191 DOI: 10.1021/acs.jafc.7b04924
J. Agric. Food Chem. 2018, 66, 1191−1196
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
were of analytical grade and purchased from Wako Pure Chemical
Industry or Sigma-Aldrich Japan. Primers were obtained from
FASMAC Co., Ltd. (Kanagawa, Japan). Enzymes and kits for DNA
manipulation were purchased from Takara Bio, Inc. (Shiga, Japan) or
New England BioLabs Japan, Inc. (Tokyo, Japan). Polymerase chain
reaction (PCR) was carried out using a GeneAmp PCR System 9700
thermal cycler (Thermo Fisher Scientiﬁc, Inc., Waltham, MA, U.S.A.)
with Tks Gﬂex DNA polymerase (Takara Bio). General genetic
manipulations of E. coli were performed according to standard
protocols. High-resolution electrospray ionization Fourier transform
mass spectrometry (HR-ESI−FT−MS) analysis was performed using
an Exactive system (Thermo Fisher Scientiﬁc, Inc.).
Bacterial Strains and Cultures. Microorganisms used in this
study are summarized in Table 1. E. coli XL1-Blue (Nippon Gene Co.,
Ltd., Tokyo, Japan), BL21(DE3) (Merck KGaA, Darmstadt,
Germany), and BW25113 (National Institute of Genetics, Shizuoka,
Japan), which is a high producer of L-cysteine (L-Cys) used for a sulfur
donor of ERG,10 were used for plasmid construction, protein
production, and ERG production, respectively. The media used were
LB and M9Y minimal medium prepared by adding 1% (w/v) glucose,
5 mM MgSO4, 0.1 mM CaCl2, and 0.1% (w/v) yeast extract (Becton,
Dickinson and Company, Franklin Lakes, NJ, U.S.A.) to M9 minimal
salts (Becton, Dickinson and Company). Ampicillin (Ap), chlor-
amphenicol (Cm), kanamycin (Km), streptomycin (Sm), and
tetracycline (Tc) were added to the media at concentrations of 100,
33, 25, 20, and 5 mg/L, if necessary. Optical density (OD) at 600 nm
was measured with a NanoDrop 2000C spectrophotometer (Thermo
Fisher Scientiﬁc, Inc.).
Preparation of Egt Recombinant Enzymes. Detailed plasmid
construction methods are described in Supplementary Methods 1 of
the Supporting Information, and the plasmids are summarized in
Table 2. Brieﬂy, EgtB, EgtC, EgtD, and EgtE were ampliﬁed by PCR
using M. smegmatis genomic DNA as the template and appropriate
primers (Table S1 of the Supporting Information), in which restriction
sites were introduced at the N and C termini. The PCR products were
respectively cloned into the expression vectors. The plasmids obtained
were introduced into E. coli BL21(DE3). A liquid culture of the
transformant in LB supplied with appropriate antibiotics was induced
by adding 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG)
when the optical density at 600 nm reached about 0.6. The cultivation
was continued for an additional 16 h at 20 °C. The production of each
recombinant enzyme was analyzed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS−PAGE) with Coomassie
Brilliant Blue staining. The puriﬁcation of each recombinant protein
was carried out using nickel−nitrilotriacetic acid (Ni−NTA) agarose
Figure 1. ERG biosynthetic pathway.
Table 1. Bacterial Strains Used in This Study
strain description source
M. smegmatis
JCM6386
ERG producer JCMa
E. coli
XL1-Blue hsdR17, recA1, endA1, gyrA96, thi-1,
supE44, relA1, lac[F′, proAB,
lacIqZΔM15, Tn10(TcR)]
Nippon Gene
BL21(DE3) F−, ompT hsdSB(rB
− mB
−) gal dcm
(DE3)
Merck
BW25113 rrnB3 ΔlacZ4787 hsdR514
Δ(araBAD)567 Δ(rhaBAD)568
rph-1
NIGb
ET1 BW25113 harboring pCF1s-MsD this study
ET2 BW25113 harboring pCF1s-MsD,
pQE1a-mMsB
this study
ET3 BW25113 harboring pCF1s-MsD,
pQE1a-mMsB,
pAC1c-hMsC/hMsE
this study
ET4 BW25113 harboring pCF1s-MsD,
pQE1a-mMsB/EcA,
pAC1c-hMsC/hMsE
this study
aJapan Collection of Microorganisms, Riken BioResource Center.
bNational Institute of Genetics.
Table 2. Plasmids Used in This Study
plasmid description source
pQE1a-Red protein production plasmid, tac promoter,
ColE1 ori, ApR
lab
stock
pCF1s-Red protein production plasmid, tac promoter,
CDF ori, SmR
lab
stock
pET-21a protein production plasmid, T7 promoter,
pBR322 ori, ApR
Merck
pACYCDuet-1 protein production plasmid, T7 promoter,
p15A ori, CmR
Merck
pQE1a-MsB pQE1a-Red derivative, production of EgtB this
study
pQE1a-mMsB pQE1a-MsB derivative, production of
MBP-fused EgtB
this
study
pQE1a-mMsB/EcA pQE1a-mMsB derivative, co-production
of MBP-fused EgtB and GshA
this
study
pQE1a-MsC pQE1a-Red derivative, production of
EgtC
this
study
pQE1a-hMsC pQE1a-MsC derivative, production of
His-tagged EgtC
this
study
pQE1a-MsE pQE1a-Red derivative, production of EgtE this
study
pQE1a-hMsE pQE1a-Red derivative, production of
His-tagged EgtE
this
study
pAC1c-hMsC/hMsE pACYCDuet-1 derivative, co-production
of His-tagged EgtC and EgtE
this
study
pCF1s-MsD pCF1s-Red derivative, production of EgtD this
study
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(QIAGEN K.K., Tokyo, Japan) or amylose resins (New England
BioLabs) according to the protocols of the manufacturer. Protein
concentrations were determined using a Bradford protein assay kit
(Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.) with bovine serum
albumin as the standard.
ERG Production. E. coli harboring plasmids carrying ERG
biosynthetic genes (Figure 2) was cultured in 3 mL of M9Y media
at 30 °C for 16 h. The cultures (1 mL) were inoculated into 50 mL of
M9Y media supplemented with 0.5 g/L L-His, 0.5 g/L L-Met, and 20
mg/L FeSO4·7H2O in 200 mL Erlenmeyer ﬂasks and incubated at 30
°C with shaking (200 rpm) for up to 72 h. Na2S2O3 was added to
media at 20 mM, if needed. IPTG was added to a ﬁnal concentration
of 0.5 mM after 3 h of cultivation. Samples (1 mL) were collected at
appropriate time points and analyzed by liquid chromatography−
electrospray ionization−mass spectrometry (LC−ESI−MS).
LC−ESI−MS Analysis of Products. Mixtures of 0.05% (v/v)
heptaﬂuorobutyric acid (HFBA) solution (180 μL) and culture broth
or enzymatic reaction solutions (20 μL) were analyzed. The LC−ESI−
MS conditions were as follows: Waters ACQUITY UPLC system
equipped with a photodiode array and a SQ Detector2 (Tokyo,
Japan); XBridge BEH C18 XP column (150 mm length × 2.0 mm
internal diameter, 2.5 μm, Waters); ﬂow rate, 0.15 mL/min;
temperature, 35 °C; mobile phase, water containing 0.05% HFBA
and 7% methanol; injection volume, 2 μL; and detection, 210 nm for
His and HER, 250 nm for Cys-HER and γGC-HER, and 258 nm for
ERG.
■ RESULTS AND DISCUSSION
The most reliable strategy for high production of ERG is
overproduction of each of the enzymes for ERG biosynthesis
and then optimization of any ineﬃcient biosynthetic step(s)
(identiﬁed by intermediate accumulation) by molecular
genetics and metabolic engineering. If no intermediates
accumulate, supply of the initial substrates, L-His, L-Glu, L-
Cys, and L-Met, should be enhanced.
ERG biosynthetic genes are present in some microorganisms,
such as actinobacteria, cyanobacteria, and α-proteobacteria.11
Among these bacteria, we selected M. smegmatis as the gene
source, because the ERG biosynthetic pathway was ﬁrst
identiﬁed in this strain and the biosynthesis genes constitute
an operon.9 Because egtB, egtC, and egtE are translationally
coupled, we ﬁrst tried expressing the egt genes as the operon
with tac and T7 promoters. We constructed several plasmids
using pQE1a-Red and pET-21a, but ERG productivities of
transformants harboring the plasmids were low (less than 0.2
mg/L). Therefore, we overexpressed egt genes stepwise under
the control of individual promoters by checking production of
recombinant enzymes and their activities by production of
intermediate compounds (HER, γGC-HER, and Cys-HER) and
ERG by in vitro experiment (Figure 1). Because E. coli has an
egtA orthologue, gshA, which is responsible for glutathione
biosynthesis,12 we expressed the other genes, egtB, egtC, egtD,
and egtE. We also prepared the intermediate compounds, which
are not commercially available, with the recombinant enzymes
to obtain standards for quantitative analysis (Supplementary
Methods 2 of the Supporting Information).
Overproduction of Recombinant Enzymes. For over-
production of Egt enzymes, we used pQE1a-Red and pCF1s-
Red, both of which are home-constructed and compatible
vectors with the tac promoter for protein production (Figure S1
of the Supporting Information). As Figure S2 of the Supporting
Information shows, transformants harboring pCF1s-MsD
carrying egtD overproduced EgtD in soluble form. To conﬁrm
whether the recombinant protein had the expected activity, we
carried out in vitro experiments with cell-free extracts
containing the recombinant enzyme.9,13 The cell-free extracts
were incubated with L-His and excess SAM. After the reaction,
the product was analyzed by LC−ESI−MS. A speciﬁc peak with
the same retention time and mass spectrometry (MS) spectrum
as the HER standard was clearly detected after 1 h of
incubation, demonstrating that EgtD converted L-His into HER
(Figure S3 of the Supporting Information).
We next overproduced recombinant EgtB using pQE1a-Red
(Figure S1 of the Supporting Information) and changed the
probable start codon TTG into ATG. However, recombinant
EgtB formed inclusion bodies in multiple culture conditions.
Therefore, a plasmid from which a recombinant enzyme is
produced as a maltose binding protein (MBP)-fused enzyme
was examined. We successfully produced a MBP-fused EgtB in
a soluble form in transformants harboring pQE1a-mMsB. To
conﬁrm whether the recombinant enzyme had the expected
activity, we carried out in vitro experiments with puriﬁed
recombinant enzyme (Figure S4 of the Supporting Informa-
tion).9 The recombinant MBP-fused EgtB was incubated with
HER and γGC for 2 h. As Figure S5 of the Supporting
Information shows, HER completely disappeared and the
formation of a new product with m/z 462.20 was detected. On
the basis of HR-ESI−FT−MS analysis of the puriﬁed
compound, the molecular formula of the product was
determined to be C17H27O8N5S (m/z: [M + H]
+ calculated
for C17H28O8N5S
+, 462.165 31; observed, 462.165 07), which
corresponded to that of γGC-HER, suggesting the formation of
Figure 2. Plasmids for ERG production.
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γGC-HER. The thus formed intermediate compound γGC-
HER was puriﬁed by high-performance liquid chromatography
(HPLC) (Supplementary Methods 2 of the Supporting
Information) and used as a standard for quantitative analysis.
Finally, overproduction of recombinant EgtC and EgtE was
examined. We ﬁrst used the same vector as for EgtB
production, but no production of either enzyme was observed.
We then examined a plasmid from which a recombinant
enzyme is produced as a His-tagged enzyme. In this case, both
EgtC and EgtE were successfully overproduced. To conﬁrm
whether the recombinant enzymes had the expected activity, we
carried out in vitro experiments with the puriﬁed recombinant
enzymes (Figure S4 of the Supporting Information).9
Recombinant EgtC was incubated with enzymatically prepared
γGC-HER. After 17 h of reaction, the product was analyzed by
LC−ESI−MS. As shown in Figure 3, a new peak with m/z
333.23 was detected and Cys-HER formation was suggested.
On the basis of HR-ESI−FT−MS analysis of the puriﬁed
compound, the molecular formula of the product was
determined to be C12H20O5N4S (m/z: [M + H]
+ calculated
for C12H21O5N4S
+, 333.122 72; observed, 333.122 90), which
corresponded to that of Cys-HER. The thus formed Cys-HER
was puriﬁed (Supplementary Methods 2 of the Supporting
Information) and used as a standard for quantitative analysis.
By adding recombinant EgtE together with EgtC into the
EgtB reaction mixture, we conﬁrmed the formation of ERG by
LC−ESI−MS analysis (Figure 4), showing that all of the
recombinant Egt enzymes possessed the expected activities.
Simultaneous Production of Egt Enzymes for ERG
Production. To reconstruct the ERG-producing pathway in E.
coli, we optimized the production conditions in a stepwise
manner: HER, then γGC-HER, and ﬁnally ERG production
(Figures 1 and 2).
The ﬁrst step was HER production. E. coli BW25113
harboring pCF1s-MsD (named strain ET1) was cultured in
M9Y medium, and 91 ± 2 mg/L HER (460 ± 10 μM) was
produced in the culture broth after 48 h. We then carried out
feeding experiments with L-His and L-Met, because amino acid
biosynthesis in E. coli is strictly regulated by feedback inhibition
and/or transcriptional repression. L-Met and L-His feeding
increased the yield: 164 ± 3 mg/L HER (833 ± 15 μM) was
produced after 48 h of cultivation (Figure 5). After this, L-His
and L-Met feeding was employed in all in vivo production
experiments.
We next carried out in vivo co-production of EgtD and EgtB
for γGC-HER production. Transformants of E. coli BW25113
carrying both pCF1s-MsD and pQE1a-mMsB (strain ET2)
were cultivated in the medium supplemented with L-His and L-
Met. As Figure 6 shows, we conﬁrmed 24 ± 1 mg/L γGC-HER
(52 ± 2 μM) production after 24 h of cultivation, indicating
that EgtB converted HER to γGC-HER using endogenous γGC
in E. coli. However, accumulation of 3-fold higher amounts of
HER (110 ± 5 mg/L) than Cys-HER (36 ± 2 mg/L) was
Figure 3. LC−ESI−MS analysis of EgtC reaction products. (a) Traces at 250 nm of reaction products. The reaction (40 μL) was carried out by
adding (i) puriﬁed recombinant EgtC (3.9 μM) or (ii) boiled EgtC to the EgtB reaction solution at 25 °C for 17 h. (b) MS spectrum of the EgtC
reaction product (ESI positive mode).
Figure 4. LC−ESI−MS analysis of EgtE reaction products. (a) Traces at 250 nm of (i) ERG standard and (ii) reaction products. The reaction (40
μL) was carried out by adding puriﬁed recombinant EgtE (2.5 μM) and EgtC (3.9 μM) (ii) to the boiled supernatant of the EgtB reaction mixture
containing 2 mM dithiothreitol at 25 °C for 17 h. (b) MS spectra of (i) ERG standard and (ii) EgtE reaction product (ESI positive mode).
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detected, suggesting that γGC-HER production was rate-
limiting.
For simultaneous expression of all egt genes, egtC and egtE,
both of which were expressed from the tac promoter of pQE1a,
were recloned into plasmid pACYCDuet-1, which is compatible
with pQE1a-Red and pCF1s-Red, to construct pAC1c-hMsC/
hMsE (Figure 2 and Supplementary Methods 2 of the
Supporting Information). The plasmid was successfully
constructed, and production of both enzymes in soluble
forms in E. coli was conﬁrmed by SDS−PAGE (Figure S6 of
the Supporting Information). The plasmid was introduced into
strain ET2 to construct strain ET3, and recombinant enzyme
production was examined. As Figure S7 of the Supporting
Information shows, all of the enzymes were produced in soluble
forms. We then examined ERG production. Strain ET3
produced 19 ± 2 mg/L (83 ± 8 μM) ERG together with 73
± 15 mg/L (370 ± 76 μM) HER in the culture broth after 72 h
of cultivation (Figure 7 and Table 3). These results suggested
that the EgtB-catalyzed reaction is a bottleneck.
ERG Production and Improvement of Rate-Limiting
Steps. Considering that EgtB was overproduced in a soluble
form in the producing strain ET3 and that it showed enough
activity in in vitro experiments, we considered that insuﬃcient
supply of γGC, the substrate of EgtB, might cause the
accumulation of HER. To test this hypothesis, overproduction
of γGC synthetase was carried out. To produce γGC
synthetase, the gshA gene from E. coli12 was cloned and
inserted into pQE1a-mMsB to construct pQE1a-mMsB/EcA.
Although MBP-fused EgtB and GshA were produced in soluble
forms in E. coli BW25113 harboring the three plasmids (strain
ET4) (Figure S8 of the Supporting Information), ERG
productivity was decreased in comparison to that of strain
ET3 to 17 ± 1 mg/L (72 ± 2 μM) after 72 h of cultivation
(Table 3). In comparison of SDS−PAGE data for strains ET3
and ET4 (Figures S7 and S8 of the Supporting Information),
soluble MBP-fused EgtB was found to be decreased in strain
ET4. This could be the reason for the reduced productivity.
We then employed another strategy to enhance the γGC
supply. In ERG biosynthesis, γGC is used as a sulfur donor. In
particular, L-Cys is a net sulfur donor, because the L-Glu moiety
of γGC is released by EgtC. Therefore, reinforcement of L-Cys
ﬂux may be eﬀective in enhancing γGC ﬂux and ERG
production. Because L-Cys addition into media was reported
to be toxic to E. coli cells,14 we employed another strategy. We
have been studying a L-Cys biosynthetic pathway in E. coli and
demonstrated that thiosulfate (S2O3
2−) was a better sulfur
source than sulfate (SO4
2−) for high L-Cys production.10 We
therefore fed thiosulfate into the growth media. When strain
ET3 was cultured in M9Y supplemented with L-Met, L-His, and
thiosulfate, ERG productivity was increased to 24 ± 4 mg/L
(104 ± 17 μM) (Table 3), indicating that reinforcement of L-
Cys ﬂux was very eﬀective in enhancing the ERG production.
In conclusion, to establish a reliable and practical method for
ERG supply, fermentative ERG production by microorganisms
was investigated. We heterologously overexpressed genes
egtBCDE of M. smegmatis in E. coli and succeeded in the
production of ERG (19 mg/L). Reinforcement of the γGC
supply by feeding of thiosulfate, a suitable sulfur donor for high
L-Cys production, resulted in higher ERG production (24 mg/
Figure 5. Culture proﬁles of strain ET1. E. coli BW25113 harboring
pCF1s-MsD (strain ET1) was cultured in M9Y medium supplemented
with L-His and L-Met. After 3 h of cultivation, 0.5 mM IPTG was
added to the medium. Data are presented as mean values with
standard errors from three independent experiments.
Figure 6. Culture proﬁles of strain ET2. E. coli BW25113 harboring
pCF1s-MsD and pQE1a-mMsB (strain ET2) was cultured in M9Y
medium supplemented with L-His and L-Met. After 3 h of cultivation,
0.5 mM IPTG was added to the medium. Data are presented as mean
values with standard errors from three independent experiments.
Figure 7. Culture proﬁles of strain ET3. E. coli BW25113 harboring
pCF1s-MsD, pQE1a-mMsB, and pAC1c-hMsC/hMsE (strain ET3)
was cultured in M9Y medium supplemented with L-His and L-Met.
After 3 h of cultivation, 0.5 mM IPTG was added to the medium. Data
are presented as mean values with standard errors from three
independent experiments.
Table 3. Culture Proﬁles of ET3 and ET4 Strainsa
strain OD
HER
(mg/L)
γGC-HER
(mg/L)
Cys-HER
(mg/L)
ERG
(mg/L)
ET3b 10.1 ± 0.5 73 ± 15 NDc 10 ± 2 19 ± 2
ET4b 8.7 ± 0.2 121 ± 12 1 ± 1 9 ± 1 17 ± 1
ET3d 11.1 ± 0.5 48 ± 17 ND 9 ± 0 24 ± 4
aData after 72 h of cultivation are presented as mean values with
standard error from three independent experiments. bET3 and ET4
were cultured in M9Y media supplemented with L-His and L-Met. cND
= not detected. dET3 was cultured in M9Y media supplemented with
L-His, L-Met, and thiosulfate.
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L). Considering that the reported ERG contents of mushrooms
were from 0.15 to 7.27 mg/g of dry weight,7 our system might
become an alternative method for ERG supply. However,
signiﬁcant amounts of HER still accumulated, suggesting that
more supply of γGC and L-Cys by metabolic engineering and
use of another EgtB with higher activity are indispensable for
high-level production of ERG.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.jafc.7b04924.
Supplementary Methods 1 and 2, vectors pQE1a-Red
and pCF1s-Red (Figure S1), SDS−PAGE analysis of
EgtD production (Figure S2), LC−ESI−MS analysis of
EgtD reaction products (Figure S3), SDS−PAGE
analysis of puriﬁed recombinant EgtB, EgtC, and EgtE
(Figure S4), LC−ESI−MS analysis of EgtB reaction
products (Figure S5), SDS−PAGE analysis of recombi-
nant EgtC and EgtE production (Figure S6), SDS−
PAGE analysis of production of recombinant Egt
enzymes in strain ET3 (Figure S7), SDS−PAGE analysis
of production of recombinant Egt enzymes and GshA in
strain ET4 (Figure S8), and primers used in this study
(Table S1) (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*Telephone: +81-11-706-7815. Fax. +81-11-706-7118. E-mail:
syasu@eng.hokudai.ac.jp.
*Telephone: +81-11-706-7815. Fax. +81-11-706-7118. E-mail:
dairi@eng.hokudai.ac.jp.
ORCID
Yasuharu Satoh: 0000-0001-6671-7758
Tohru Dairi: 0000-0002-3406-7970
Funding
This work was supported by the Science and Technology
Research Promotion Program for Agriculture, Forestry, Fish-
eries and Food Industry (26027AB) from Ministry of
Agriculture, Forestry and Fisheries (MAFF), Japan (to Iwao
Ohtsu).
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
The authors are grateful to Professor Tsutomu Sato (Graduate
School of Science and Technology, Niigata University, Niigata,
Japan) for providing M. smegmatis genomic DNA. The authors
thank James Allen from Edanz Group (www.edanzediting.com)
for editing a draft of this manuscript.
■ NOMENCLATURE
ERG = ergothioneine
HER = hercynine
γGC = γ-glutamylcysteine
γGC-HER = hercynyl-γ-glutamylcysteine sulfoxide
Cys-HER = hercynylcysteine sulfoxide
SAM = S-adenosylmethionine
SAH = S-adenosylhomocysteine
L-His = L-histidine
L-Glu = L-glutamate
L-Cys = L-cysteine
L-Met = L-methionine
HR-ESI−FT−MS = high-resolution electrospray ionization
Fourier transform mass spectrometry
MBP = maltose-binding protein
SDS−PAGE = sodium dodecyl sulfate polyacrylamide gel
electrophoresis
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